0. Advocacy Graphic

 Leading the movement to transform America's addiction treatment infrastructure and expand access to research-validated, results-based care


ASAM's Advocacy Principles

Advocacy Webpage Graphics Teach It
TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma
Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of addiction medicine so that more patients receive high-quality, evidence-based care
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to coordinated, comprehensive care
Advocacy Homepage HR 6 Graphic

It's time we treat addiction like other chronic diseases 


Advocacy Committees & Councils

ASAM's advocacy could not happen if not for the dedicated effort of our members.

0. Find a Policy Statement 1 - cropped

Public Policy Statements

Learn about ASAM's position on current policy issues.

Teamwork - smallest


ASAM is proud to work collaboratively with others to improve the lives of those living with addiction.
0. Advocacy Toolkits

Advocacy Toolkits

ASAM provides toolkits to help you advocate for public policies that advance addiction medicine and promote access to treatment

Legislative Tracker Graphic


ASAM Responds to RFI from ASPE Regarding the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

by | Aug 28, 2019


On August 28, ASAM submitted a comment letter to the Department of Health and Human Services’ Assistant Secretary for Planning and Evaluation (ASPE) in response to an RFI required by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. 


In its letter, ASAM discussed the current obstacles to legitimate patient access to controlled substances, including efforts by distributors and regulators to prevent diversion of controlled substances that may be inadvertently restricting patient access to schedule III medications used in the treatment of opioid use disorder. ASAM also stressed the importance of increasing access to medical education, training opportunities, and comprehensive clinical guidance for pain management and opioid prescribing. Specifically, ASAM mentioned its Continuing Medical Education (CME) offerings, as well as The ASAM Handbook on Pain and Addiction, both powerful resources for educating the addiction treatment workforce. Finally, ASAM’s letter highlighted the vital role of state prescription drug monitoring programs (PDMP) in ensuring quality, safe and effective coordination of care for those suffering from substance use disorder.


Read the letter here.